Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: April 1, 2020
Clear
SKU: GMS-1222 Category:

The global market for leukapheresis products is expected to reach USD 28.2 million by 2024, growing over the forecast period at a CAGR of 7%. Increasing leukemia incidence and prevalence, growing demand for leukopaks for research applications, and increasing blood donations are some of the factors expected to drive the Leukapheresis market.

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) - 2019 to 2024 1

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) - 2019 to 2024 2

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) - 2019 to 2024 3

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) - 2019 to 2024 4

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) - 2019 to 2024 5

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) - 2019 to 2024 6

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) - 2019 to 2024 7

Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Application (Therapeutic, Research), Leukopak (Non-Mobilized, Mobilized, Human Primary Cells), End User (Research Institute, Hospitals) - 2019 to 2024 8

1 Global Leukapheresis Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Leukapheresis Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Leukapheresis Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Leukapheresis Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Leukapheresis Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Leukapheresis Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Leukapheresis Market – By Type (Market Size – & million/billion)
8.1 Leukapheresis Devices
8.2 Leukapheresis Disposables

9 Global Leukapheresis Market – By Application
9.1 Research Applications
9.2 Therapeutic Applications

10 Global Leukapheresis Market – By End-User
10.1 Blood Component Providers and Blood Centers
10.2 Academic and Research Institutes
10.3 Pharmaceutical and Biotechnology Companies
10.4 Hospitals and Transfusion Centers

11 Global Leukapheresis Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Leukapheresis Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Leukapheresis Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
13.3 Fresenius Se & Co. KGaA
13.4 Haemonetics Corporation
13.5 Hemacare Corporation
13.6 Key Biologics, LLC.
13.7 Stemcell Technologies, Inc.
13.8 Caltag Medsystems Limited
13.9 Terumo BCT
13.10 ALLCells, LLC.
13.11 Stemexpress, LLC.
13.12 Company 11 & more

14 Global Leukapheresis Market – Appendix
14.1 Sources
14.2 Abbreviations